Abstracts of the 21st ECCMID (European Society of Clinical Microbiology and Infectious Diseases)/27th ICC. Milan, Italy. May 7-10, 2011.
出版信息
Clin Microbiol Infect. 2011 May;17 Suppl 4(Suppl 4):S1-895, A1-4. doi: 10.1111/j.1469-0691.2011.03557.x.
Abstract
摘要
相似文献
1
Abstracts of the 21st ECCMID (European Society of Clinical Microbiology and Infectious Diseases)/27th ICC. Milan, Italy. May 7-10, 2011.第21届欧洲临床微生物学与传染病学会（ECCMID）/第27届国际传染病大会摘要。意大利米兰。2011年5月7日至10日。
Clin Microbiol Infect. 2011 May;17 Suppl 4(Suppl 4):S1-895, A1-4. doi: 10.1111/j.1469-0691.2011.03557.x.
2
Abstracts of the 19th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Helsinki, Finland. May 16-19, 2009.第19届欧洲临床微生物学和传染病大会摘要。芬兰赫尔辛基。2009年5月16日至19日。
Clin Microbiol Infect. 2009 May;15 Suppl 4:S1-678. doi: 10.1111/j.1469-0691.2009.02857.x.
3
Abstracts of the 20th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria. April 10-13, 2010.第20届欧洲临床微生物学和传染病大会摘要。奥地利维也纳。2010年4月10日至13日。
Clin Microbiol Infect. 2010 Apr;16 Suppl 2(Suppl 2):S1-720. doi: 10.1111/j.1469-0691.2010.03238.x.
4
Report from the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) and 27th International Congress of Chemotherapy (ICC), Milan, Italy, May 7-10, 2011.
Infect Disord Drug Targets. 2012 Aug;12(4):297-300. doi: 10.2174/187152612801319267.
5
Abstracts of the 17th European Congress of Clinical Microbiology and Infectious Diseases/25th ICC. Munich, Germany. March 31-April 3, 2007.第17届欧洲临床微生物学和传染病大会/第25届国际传染病大会摘要。德国慕尼黑。2007年3月31日至4月3日。
Clin Microbiol Infect. 2007 Apr;13 Suppl 1(Suppl 1):S1-727. doi: 10.1111/j.1469-0691.2007.01732.x.
6
Abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice, France. April 1-4, 2006.第16届欧洲临床微生物学和传染病大会摘要。法国尼斯。2006年4月1日至4日。
Clin Microbiol Infect. 2006 Apr;12 Suppl 4:8-2270. doi: 10.1111/j.1470-9465.2006.12_4_1426.x.
7
Abstracts of the 18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. April 19-22, 2008.第18届欧洲临床微生物学与传染病大会摘要。西班牙巴塞罗那。2008年4月19 - 22日。
Clin Microbiol Infect. 2008 May;14 Suppl 7(Suppl 7):S1-815. doi: 10.1111/j.1469-0691.2008.02006.x.
8
Abstracts of the 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, United Kingdom. March 31-April 3, 2012.
Clin Microbiol Infect. 2012 Apr;18 Suppl 3:1-902.
9
Progress towards meeting the challenges in clinical microbiology and infectious diseases. Proceedings of a Workshop of the European Society of Clinical Microbiology and Infectious Diseases. March 17-19, 2004. Leuven, Belgium.应对临床微生物学和传染病挑战的进展。欧洲临床微生物学和传染病学会研讨会论文集。2004年3月17 - 19日。比利时鲁汶
Clin Microbiol Infect. 2005 Apr;11 Suppl 1:vii; 1-51. doi: 10.1111/j.1469-0691.2005.01157.x.
10
A report from the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy (May 7-10, 2011 - Milan, Italy).来自第21届欧洲临床微生物学和传染病大会以及第27届国际化疗大会的报告（2011年5月7日至10日——意大利米兰）。
Drugs Today (Barc). 2011 Jun;47(6):469-83. doi: 10.1358/dot.2011.47.6.1635344.
本文引用的文献
1
Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction.尿路致病性大肠杆菌 P 型菌毛和 1 型菌毛在活体宿主中协同作用，促进肾脏定植，导致肾单位阻塞。
PLoS Pathog. 2011 Feb;7(2):e1001298. doi: 10.1371/journal.ppat.1001298. Epub 2011 Feb 24.
2
Divergent mechanisms for passive pneumococcal resistance to β-lactam antibiotics in the presence of Haemophilus influenzae.在流感嗜血杆菌存在的情况下，肺炎链球菌对β-内酰胺类抗生素产生被动耐药的不同机制。
J Infect Dis. 2011 Feb 15;203(4):549-55. doi: 10.1093/infdis/jiq087. Epub 2011 Jan 10.
3
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.奥司他韦耐药的大流行（H1N1）2009 病毒在 48 小时内出现。
Emerg Infect Dis. 2010 Oct;16(10):1633-6. doi: 10.3201/eid1610.100688.
4
Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline.急性中耳炎：从诊断到预防。意大利指南摘要
Int J Pediatr Otorhinolaryngol. 2010 Nov;74(11):1209-16. doi: 10.1016/j.ijporl.2010.08.016. Epub 2010 Sep 16.
5
Serious infections caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的严重感染。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S183-97. doi: 10.1086/653519.
6
Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.b 型流感嗜血杆菌和肺炎球菌结合疫苗的全球现状：证据、政策和引入情况。
Curr Opin Infect Dis. 2010 Jun;23(3):236-41. doi: 10.1097/QCO.0b013e328338c135.
7
The epidemiology of meningococcal disease and the impact of vaccines.脑膜炎奈瑟菌病的流行病学和疫苗的影响。
Expert Rev Vaccines. 2010 Mar;9(3):285-98. doi: 10.1586/erv.10.3.
8
Otitis media and its consequences: beyond the earache.中耳炎及其后果：不仅仅是耳痛。
Lancet Infect Dis. 2010 Mar;10(3):195-203. doi: 10.1016/S1473-3099(10)70012-8.
9
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.万古霉素中介和耐万古霉素金黄色葡萄球菌（hVISA）在 9 家美国医院血流感染中的发生情况。
J Antimicrob Chemother. 2009 Nov;64(5):1024-8. doi: 10.1093/jac/dkp319. Epub 2009 Sep 10.
10
Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.美国门诊环境中急性呼吸道感染的抗生素处方率。
JAMA. 2009 Aug 19;302(7):758-66. doi: 10.1001/jama.2009.1163.
Zotero 插件